Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Darpolor, Moses M ^a,b   Molthen, Robert C ^b   Schmainda, Kathleen M ^b  

^a Marquette University   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; CD31 ANTIGEN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; CELL DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GLIOSARCOMA; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLOGY; MORPHOMETRICS; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; ANIMAL; BLOOD VESSEL; BRAIN CIRCULATION; DISEASE MODEL; FISCHER 344 RAT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERFUSION; VASCULARIZATION;

RATTUS;

ANIMALS; ANTIGENS, CD31; BLOOD VESSELS; CEREBROVASCULAR CIRCULATION; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GLIOSARCOMA; MAGNETIC RESONANCE IMAGING; PERFUSION; RATS; RATS, INBRED F344; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79551648296     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016621     Document Type: Article

References (32)

1. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, et al. (1996) Timedependent vascular regression and permeability changes in established xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 93: 14765-14770.
2. Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, et al. (2001) In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nature Medicne 7: 864-868.
3. Baish JW, Jain RK (2000) Fractals and cancer. Cancer Research 60: 3683-3688.
4. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, et al. (2000) Openings between defective endothelia cells explain tumor vessels leakiness. American Journal of Pathology 156: 1363-1380.
5. Batchelor TT, Sorensen AG, di Tomaso E, Zhang W, Duda DG, et al. (2007) AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients. Cancer Cell 11: 83-95.
6. Kadambi A, Carreira CM, Yun C, Padera TP, Dolmans DE, et al. (2001) Vascular Endothelial Growth Factor (VEGF)-C Differentially Affects Tumor Vascular Function and Leukocyte Recruitment: Role of VEGF-Receptor 2 and Host VEGF-A. Cancer Research 61: 2404-2408.
7. Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, AncukiewiczM, et al. (2000) Anti-Vascular Endothelial Growth Factor Treatment Augments Tumor Radiation Response under Normoxic of Hypoxic Conditions. Cancer Research 60: 5565-5570.
8. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, et al. (2002) Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absense of mural cells. J Clin Invest 110: 1619-1628.
9. Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, et al. (1999) Marked Antiangiogenic and Antitumor Efficacy of AG3340 in Chemoresistant Human Non-Small Cell Lung Cancer Tumors: Single Agent and Combination Chemotherapy Studies. Clinical Cancer Research 5: 1905-1917.
10. Bello L, Carabba G, Giussani C, Lucini V, Cerutti F, et al. (2001) Low-dose Chemotherapy Combined with an Antiangiogenic Drug Reduces Human Glioma Growth in Vivo. Cancer Research 61: 7501-7506.
11. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, et al. (1999) Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation. Cancer Research 59: 3374-3378.
12. Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, et al. (1998) Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Research 58: 5686-5689.
13. Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, et al. (1998) Combined effects of angiostatin and ionization radiation in antitumor therapy. Nature 394: 287-291.
14. Quarles CC, Krouwer HGJ, Rand SD, Schmainda KM (2005) Dexamethasone Normalizes Brain Tumor Hemodynamics as Indicated by Dynamic Susceptibility Contrast MRI Perfusion Parameters. Technol Cancer Res Treat 4: 245-249.
15. Quarles CC, Schmainda KM (2007) Assessment of the Morphological and Functional Effects of the Anti-Angiogenic Agent SU11657 on 9L Gliosarcoma Vasculature Using Dynamic Susceptibility Contrast MRI. Magn Reson Med 57: 680-687.
16. Badruddoja MA, Krouwer HGJ, Rand SD, Rebro KJ, Pathak AP, et al. (2003) Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro-Oncology 5: 235-243.
17. Heiss JD, Papavassiliou E, Merril MJ, Nieman L, Knightly JJ, et al. (1996) Mechanism of Dexamethasone Suppression of brain Tumor-associated Vascular Permeability in Rats. J Clinical Investigation 98: 1400-1408.
18. Moffat BA, Chen M, Kariaapper MST, Hamstra DA, Hall DE, et al. (2006) Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D. Clin Cancer Res 12: 1525.
19. Machein MR, Kullmer J, Ronicke V, Machein U, Kreig M, et al. (1999) Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathology and Applied Neurobiology 25: 104-112.
20. Portnow J, Sulemans S, Grossman SA, Eller S, Carson K (2002) A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas. Neuro-oncol 4: 22-25.
21. Wolff JE, Guerin C, Laterrra J, Bressler J, Indurti RR, et al. (1993) Dexamethasone reduces vascular density and plasmonigen activator activity in 9L rat brain tumors. Brain Reasearch 604: 79-85.
22. Wolff JE, Molenkamp G, Hotfilder M, Laterra J (1997) Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo. Klin Padiatr 209: 275-227.
23. Shen T, Weissleder R, Papisov M, Bogdanov A, Jr., Brady TJ (1993) Monocrytalline iron oxide nanocompounds (MION): physicochemical properties. Magnetic Resonance in Medicine 29: 599-604.
24. Pathak AP, Schmainda KM, Ward BD, Linderman JR, Rebro KJ, et al. (2001) MR-Derived Cerebral Blood Volume Maps: Issues Regarding Histological Validation and Assessment of Tumor Angiogenesis. Magnetic Resonance in Medicine 46: 735-747.
25. Quarles CC, Ward BD, Schmainda KM (2005) Improving the Reliability of Obtaining Tumor hemodynamic Parameters in the Presence of Contrast Agent Extravasation. Magn Reson Imaging 53: 1307-1316.
26. Karau KL, Molthen RC, Dhyani A, Haworth ST, Hanger CC, et al. (2001) Pulmonary arterial morphometry from microfocal X-ray computed tomography. Am J heart Circ Physiol 281: H2747-H2203.
27. Molthen RC, Karau KL, Dawson CA (2004) Quantitative models of rat pulmonary arterial tree morphometry applied to hypoxia-induced arterial remodeling. J Appl Physiol 97: 2372-2384.
28. Feldkamp LA, Davis LC, Kress JW (1984) Pratical cone-beam algorithm. J Opt Soc Am A 1: 612-619.
29. Johnson RH, Hu H, Haworth ST, Cho PS, Dawson CA, et al. (1998) Feldkamp and circle-and-line cone-beam reconstruction for 3D micro-CT of vascular networks. Phys Med Biol 43: 929-940.
30. Robb RA (2001) The Biomedical Imaging Resource at Mayo Clinic. Guest Editorial. IEEE Transactions on Medical Imaging 20: 854-867.
31. Robb RA, Barillot C (1989) Interactive display and analysis of 3-D medical images. IEEE Transactions on Medical Imaging 8: 217-226.
32. Robb RA, Hanson DP, Karwoski RA, Larson AG, Workman EL, et al. (1989) ANALYZE: a comprehensive, operator-interactive software package for multidimensional medical image display and analysis. Computerized Medical Imaging and Graphics 13: 433-454.